| Sequence Name |
Description |
Length |
Blast Hits |
min E-value |
Similarity |
GO hits |
GO names |
Enzyme Codes |
InterPro Scan |
| contig05001 |
---NA--- |
295 |
0 |
|
|
0 |
|
|
|
| contig05002 |
---NA--- |
296 |
0 |
|
|
0 |
|
|
|
| contig05003 |
solute carrier family member 1a |
246 |
20 |
2.15E-33 |
93.65% |
5 |
F:receptor activity; P:phosphate transport; C:membrane attack complex; F:inorganic phosphate transmembrane transporter activity; F:symporter activity |
|
|
| contig05004 |
isoform cra_a |
387 |
10 |
4.21E-29 |
64.90% |
0 |
|
|
|
| contig05005 |
---NA--- |
405 |
0 |
|
|
0 |
|
|
|
| contig05006 |
transducin-like enhancer of split 3 (e drosophila) isoform 1 |
212 |
20 |
3.55E-36 |
100.00% |
5 |
P:spermatogenesis; P:cell differentiation; P:multicellular organismal development; C:nucleus; P:regulation of transcription, DNA-dependent |
|
|
| contig05007 |
glucosamine (n-acetyl)-6-sulfatase |
262 |
20 |
6.80E-43 |
88.40% |
5 |
P:keratan sulfate catabolic process; F:N-acetylglucosamine-6-sulfatase activity; C:lysosome; F:sulfate binding; F:calcium ion binding |
EC:3.1.6.14 |
|
| contig05008 |
---NA--- |
605 |
0 |
|
|
0 |
|
|
|
| contig05009 |
ornithine carbamoyltransferase |
250 |
20 |
7.60E-39 |
89.60% |
10 |
P:protein oligomerization; F:ornithine carbamoyltransferase activity; P:arginine biosynthetic process; C:mitochondrial inner membrane; F:phospholipid binding; P:urea cycle; F:phosphate binding; C:ornithine carbamoyltransferase complex; C:mitochondrial matrix; F:amino acid binding |
EC:2.1.3.3 |
|
| contig05010 |
f-box and leucine-rich repeat protein 5 |
339 |
20 |
8.70E-35 |
56.10% |
4 |
F:F; P:P; F:protein binding; C:C |
|
|
| contig05011 |
---NA--- |
272 |
0 |
|
|
0 |
|
|
|
| contig05012 |
---NA--- |
431 |
0 |
|
|
0 |
|
|
|
| contig05013 |
unnamed protein product [Tetraodon nigroviridis] |
256 |
1 |
3.10E-11 |
79.00% |
0 |
|
|
|
| contig05014 |
---NA--- |
274 |
0 |
|
|
0 |
|
|
|
| contig05015 |
uba and wwe domain containing 1 |
287 |
20 |
1.64E-36 |
100.00% |
8 |
C:cytoplasm; P:histone ubiquitination; F:DNA binding; F:protein binding; P:protein polyubiquitination; P:mRNA transport; F:ubiquitin-protein ligase activity; C:nucleus |
EC:6.3.2.19 |
|
| contig05016 |
---NA--- |
285 |
0 |
|
|
0 |
|
|
|
| contig05017 |
alpha- -mannosylglycoprotein 6-beta-n-acetylglucosaminyltransferase b |
251 |
15 |
1.49E-10 |
87.93% |
4 |
F:metal ion binding; C:Golgi membrane; C:integral to membrane; F:alpha-1,6-mannosyl-glycoprotein 6-beta-N-acetylglucosaminyltransferase activity |
EC:2.4.1.155 |
|
| contig05018 |
---NA--- |
270 |
0 |
|
|
0 |
|
|
|
| contig05019 |
---NA--- |
258 |
0 |
|
|
0 |
|
|
|
| contig05020 |
proteasome ( macropain) 26s non- 2 |
676 |
20 |
2.50E-72 |
99.00% |
3 |
C:cytosol; F:binding; C:protein complex |
|
|
| contig05021 |
low density lipoprotein receptor adaptor protein 1 |
446 |
20 |
1.09E-40 |
92.80% |
18 |
C:cytosol; F:protein binding, bridging; P:regulation of protein binding; C:basal plasma membrane; P:positive regulation of receptor-mediated endocytosis; ; F:protein C-terminus binding; F:phosphotyrosine binding; F:receptor activity; F:clathrin binding; F:receptor binding; C:early endosome; C:AP-2 adaptor complex; F:receptor signaling complex scaffold activity; P:cholesterol homeostasis; ; C:AP-1 adaptor complex; P:cholesterol metabolic process |
|
|
| contig05022 |
---NA--- |
262 |
0 |
|
|
0 |
|
|
|
| contig05023 |
bystin-like |
891 |
20 |
2.72E-95 |
93.35% |
5 |
C:cytoplasm; P:cell adhesion; C:nucleus; P:female pregnancy; P:ribosome biogenesis |
|
|
| contig05024 |
tiny fragments locus 9c |
242 |
20 |
7.00E-16 |
79.85% |
4 |
F:nucleic acid binding; P:metabolic process; F:nucleotide binding; F:S-adenosylmethionine-dependent methyltransferase activity |
|
|
| contig05025 |
anterior pharynx defective 1 homolog a ( elegans) |
500 |
20 |
2.77E-63 |
84.95% |
13 |
F:endopeptidase activity; P:membrane protein ectodomain proteolysis; P:metanephros development; P:membrane protein intracellular domain proteolysis; C:membrane attack complex; F:protein binding; P:Notch receptor processing; P:amyloid precursor protein catabolic process; P:protein processing; C:endoplasmic reticulum membrane; P:positive regulation of catalytic activity; C:Golgi apparatus; C:integral to plasma membrane |
|
|
| contig05026 |
---NA--- |
278 |
0 |
|
|
0 |
|
|
|
| contig05027 |
---NA--- |
521 |
0 |
|
|
0 |
|
|
|
| contig05028 |
ctp synthase |
478 |
20 |
4.59E-76 |
91.55% |
5 |
P:CTP biosynthetic process; P:glutamine metabolic process; P:response to drug; F:protein binding; F:CTP synthase activity |
EC:6.3.4.2 |
|
| contig05029 |
---NA--- |
346 |
0 |
|
|
0 |
|
|
|
| contig05030 |
---NA--- |
325 |
0 |
|
|
0 |
|
|
|
| contig05031 |
---NA--- |
279 |
0 |
|
|
0 |
|
|
|
| contig05032 |
histone h4 |
383 |
20 |
7.71E-39 |
99.55% |
4 |
C:nucleosome; F:DNA binding; P:nucleosome assembly; C:nucleus |
|
|
| contig05033 |
---NA--- |
277 |
0 |
|
|
0 |
|
|
|
| contig05034 |
sec23 homolog b ( cerevisiae) |
243 |
20 |
2.82E-33 |
95.80% |
9 |
P:cartilage development; F:zinc ion binding; F:protein binding; C:COPII vesicle coat; P:ER to Golgi vesicle-mediated transport; C:perinuclear region of cytoplasm; P:intracellular protein transport; P:embryonic neurocranium morphogenesis; C:endoplasmic reticulum |
|
|
| contig05035 |
transmembrane protein 126a |
541 |
20 |
3.01E-46 |
74.55% |
2 |
C:integral to membrane; C:mitochondrion |
|
|
| contig05036 |
phosphoglycerate mutase 1 |
287 |
20 |
3.31E-21 |
97.75% |
5 |
F:2,3-bisphospho-D-glycerate 2-phosphohydrolase activity; F:phosphoglycerate mutase activity; F:bisphosphoglycerate mutase activity; P:glycolysis; C:cytosol |
EC:3.1.3.13; EC:5.4.2.1; EC:5.4.2.4 |
|
| contig05037 |
---NA--- |
256 |
0 |
|
|
0 |
|
|
|
| contig05038 |
cyclin-dependent kinase 5 |
589 |
20 |
1.22E-44 |
91.90% |
60 |
C:cytoskeleton; P:axon extension; P:protein amino acid autophosphorylation; P:hippocampus development; P:regulation of cell migration; P:behavioral response to cocaine; P:dendrite morphogenesis; P:synaptic vesicle endocytosis; P:cell-matrix adhesion; C:growth cone; P:cell division; P:serine phosphorylation of STAT3 protein; P:positive regulation of calcium ion-dependent exocytosis; P:Schwann cell development; P:cortical actin cytoskeleton organization; C:lamellipodium; C:neuromuscular junction; C:cytosol; P:peripheral nervous system neuron development; C:neuronal cell body; P:sensory perception of pain; P:negative regulation of neuron apoptosis; P:associative learning; P:regulation of excitatory postsynaptic membrane potential; F:p53 binding; C:filopodium; P:positive regulation of neuron apoptosis; P:synaptic transmission, glutamatergic; C:cell junction; P:synaptic transmission, dopaminergic; F:tau-protein kinase activity; P:skeletal muscle tissue development; P:visual learning; P:negative regulation of protein ubiquitination; C:axon; P:embryonic development; C:cyclin-dependent protein kinase 5 holoenzyme complex; P:central nervous system neuron development; F:cyclin-dependent protein kinase activity; P:corpus callosum development; P:cerebellar cortex formation; P:regulated secretory pathway; F:acetylcholine receptor activator activity; P:negative regulation of synaptic plasticity; F:ATP binding; P:negative regulation of protein export from nucleus; P:cell proliferation; C:dendrite; P:receptor clustering; F:ErbB-2 class receptor binding; F:histone kinase activity; P:negative regulation of cell cycle; P:motor axon guidance; P:receptor catabolic process; C:nucleolus; F:ErbB-3 class receptor binding; P:positive regulation of protein kinase activity; P:layer formation in the cerebral cortex; P:response to wounding; P:neuron migration |
EC:2.7.11.26; EC:2.7.11.22 |
|
| contig05039 |
---NA--- |
247 |
0 |
|
|
0 |
|
|
|
| contig05040 |
cmp-sialic acid transporter |
439 |
20 |
3.61E-73 |
93.25% |
5 |
C:Golgi membrane; P:nucleotide-sugar transport; F:nucleotide-sugar transmembrane transporter activity; F:sugar:hydrogen symporter activity; C:integral to membrane |
|
|
| contig05041 |
---NA--- |
908 |
0 |
|
|
0 |
|
|
|
| contig05042 |
alanyl-trna synthetase domain containing 1 |
562 |
20 |
3.47E-27 |
81.60% |
5 |
C:cytoplasm; F:alanine-tRNA ligase activity; P:alanyl-tRNA aminoacylation; F:protein binding; F:ATP binding |
EC:6.1.1.7 |
|
| contig05043 |
phosphatidylinositol transfer alpha |
254 |
20 |
2.70E-39 |
87.20% |
9 |
C:cytoplasm; P:lipid metabolic process; F:phosphatidylinositol transporter activity; F:phospholipid binding; F:protein binding; P:visual perception; C:integral to membrane; P:phospholipid transport; F:phosphatidylcholine transmembrane transporter activity |
|
|
| contig05044 |
---NA--- |
264 |
0 |
|
|
0 |
|
|
|
| contig05045 |
---NA--- |
636 |
0 |
|
|
0 |
|
|
|
| contig05046 |
novel protein |
316 |
20 |
8.98E-35 |
62.25% |
0 |
|
|
|
| contig05047 |
fcgbp protein |
574 |
20 |
4.11E-18 |
45.30% |
2 |
P:binding of sperm to zona pellucida; P:cell adhesion |
|
|
| contig05048 |
cap-gly domain containing linker protein member 4 |
259 |
20 |
4.74E-36 |
79.05% |
0 |
|
|
|
| contig05049 |
---NA--- |
254 |
0 |
|
|
0 |
|
|
|
| contig05050 |
dep domain containing 1a |
253 |
20 |
2.91E-17 |
82.00% |
3 |
C:intracellular; F:GTPase activator activity; |
|
|
| contig05051 |
actin-like 6a |
498 |
20 |
4.76E-31 |
100.00% |
9 |
P:regulation of transcription, DNA-dependent; P:regulation of cell growth; C:chromatin remodeling complex; P:proteolysis; F:ATP binding; F:protein binding; F:aspartic-type endopeptidase activity; F:chromatin binding; P:chromatin remodeling |
EC:3.4.23.0 |
|
| contig05052 |
---NA--- |
147 |
0 |
|
|
0 |
|
|
|
| contig05053 |
translation machinery-associated protein 16 |
250 |
20 |
4.32E-34 |
78.10% |
2 |
F:F; C:C |
|
|
| contig05054 |
---NA--- |
260 |
0 |
|
|
0 |
|
|
|
| contig05055 |
---NA--- |
631 |
0 |
|
|
0 |
|
|
|
| contig05056 |
---NA--- |
339 |
0 |
|
|
0 |
|
|
|
| contig05057 |
---NA--- |
296 |
0 |
|
|
0 |
|
|
|
| contig05058 |
centromere protein i |
374 |
2 |
1.03E-06 |
77.00% |
0 |
|
|
|
| contig05059 |
voltage-dependent anion channel 1 |
719 |
20 |
1.38E-18 |
99.90% |
13 |
P:apoptosis; P:learning; C:integral to membrane; C:mitochondrial inner membrane; P:nerve-nerve synaptic transmission; P:anion transport; C:extracellular space; C:mitochondrial outer membrane; F:protein binding; P:mitochondrial calcium ion transport; F:voltage-gated anion channel activity; P:behavioral fear response; C:plasma membrane |
|
|
| contig05060 |
---NA--- |
431 |
0 |
|
|
0 |
|
|
|
| contig05061 |
---NA--- |
333 |
0 |
|
|
0 |
|
|
|
| contig05062 |
trf1-interacting ankyrin-related adp-ribose polymerase |
241 |
20 |
1.04E-19 |
84.95% |
10 |
P:peptidyl-serine phosphorylation; C:Golgi membrane; P:peptidyl-threonine phosphorylation; C:nuclear pore; C:chromosome, telomeric region; F:protein binding; P:telomere maintenance via telomerase; P:intracellular protein transmembrane transport; F:NAD+ ADP-ribosyltransferase activity; P:mRNA transport |
EC:2.4.2.30 |
|
| contig05063 |
eukaryotic translation initiation factor subunit c |
603 |
20 |
1.10E-51 |
95.45% |
4 |
C:eukaryotic translation initiation factor 3 complex; P:regulation of translational initiation; F:translation initiation factor activity; F:ribosome binding |
|
|
| contig05064 |
ataxin 7-like 2 |
308 |
2 |
3.45E-23 |
78.00% |
2 |
P:P; C:C |
|
|
| contig05065 |
dermal papilla-derived protein 6 homolog |
1566 |
20 |
2.60E-109 |
57.05% |
1 |
P:transcription, DNA-dependent |
|
|
| contig05066 |
member ras onocogene family |
492 |
20 |
1.56E-31 |
69.80% |
5 |
P:neurotransmitter secretion; F:GTP binding; F:protein binding; P:transport; C:membrane |
|
|
| contig05067 |
---NA--- |
356 |
0 |
|
|
0 |
|
|
|
| contig05068 |
dead (asp-glu-ala-asp) box polypeptide 52 |
283 |
20 |
1.87E-37 |
76.55% |
5 |
F:RNA helicase activity; F:ATP-dependent helicase activity; F:nucleic acid binding; F:ATP binding; P:rRNA processing |
|
|
| contig05069 |
zinc finger ccch-type containing 14 |
455 |
20 |
1.10E-53 |
77.15% |
1 |
F:zinc ion binding |
|
|
| contig05070 |
thyroid transcription factor 1-associated protein 26 homolog |
343 |
6 |
2.15E-12 |
68.67% |
0 |
|
|
|
| contig05071 |
---NA--- |
251 |
0 |
|
|
0 |
|
|
|
| contig05072 |
iron-responsive element binding protein 2 |
230 |
20 |
1.02E-14 |
90.50% |
7 |
C:cytoplasm; F:iron-responsive element binding; P:cellular iron ion homeostasis; F:iron ion binding; P:tricarboxylic acid cycle; F:4 iron, 4 sulfur cluster binding; F:aconitate hydratase activity |
EC:4.2.1.3 |
|
| contig05073 |
translocase of outer mitochondrial membrane 70 homolog a |
254 |
20 |
1.14E-13 |
100.00% |
5 |
F:receptor activity; F:protein binding; C:integral to membrane; C:mitochondrial outer membrane; P:protein transport |
|
|
| contig05074 |
---NA--- |
299 |
0 |
|
|
0 |
|
|
|
| contig05075 |
rad54-like ( cerevisiae) |
257 |
20 |
2.00E-34 |
86.60% |
10 |
F:DNA-dependent ATPase activity; F:helicase activity; F:DNA binding; P:response to drug; P:meiosis; P:double-strand break repair via homologous recombination; P:chromosome organization; P:response to ionizing radiation; F:ATP binding; C:nucleus |
|
|
| contig05076 |
mpv17 protein |
307 |
17 |
3.35E-10 |
85.71% |
2 |
C:membrane attack complex; C:mitochondrial inner membrane |
|
|
| contig05077 |
---NA--- |
256 |
0 |
|
|
0 |
|
|
|
| contig05078 |
mitochondrial 39s ribosomal protein l3 |
317 |
7 |
1.70E-17 |
68.00% |
4 |
F:structural constituent of ribosome; P:translation; C:ribonucleoprotein complex; C:ribosome |
|
|
| contig05079 |
potassium channel tetramerisation domain containing 14 |
584 |
20 |
3.75E-75 |
75.20% |
4 |
C:voltage-gated potassium channel complex; F:voltage-gated potassium channel activity; F:protein binding; P:potassium ion transport |
|
|
| contig05080 |
unnamed protein product [Tetraodon nigroviridis] |
472 |
1 |
5.58E-05 |
95.00% |
0 |
|
|
|
| contig05081 |
twisted gastrulation homolog 1 |
432 |
20 |
1.53E-79 |
88.60% |
11 |
C:signal recognition particle, endoplasmic reticulum targeting; P:negative regulation of BMP signaling pathway; P:camera-type eye development; P:forebrain development; P:hemopoiesis; P:negative regulation of osteoblast differentiation; C:extracellular space; F:protein binding; P:positive regulation of BMP signaling pathway; P:blood vessel development; P:mesoderm formation |
EC:3.6.5.4 |
|
| contig05082 |
dehydrogenase reductase (sdr family) member 7b |
248 |
20 |
1.15E-18 |
84.10% |
6 |
F:binding; F:oxidoreductase activity; C:peroxisomal membrane; C:membrane attack complex; P:metabolic process; P:peroxisome organization |
|
|
| contig05083 |
---NA--- |
386 |
0 |
|
|
0 |
|
|
|
| contig05084 |
---NA--- |
299 |
0 |
|
|
0 |
|
|
|
| contig05085 |
abhydrolase domain containing 5 |
355 |
20 |
1.41E-32 |
74.05% |
3 |
C:lipid particle; F:hydrolase activity; P:primary metabolic process |
|
|
| contig05086 |
unnamed protein product [Tetraodon nigroviridis] |
285 |
1 |
1.30E-17 |
90.00% |
0 |
|
|
|
| contig05087 |
---NA--- |
787 |
0 |
|
|
0 |
|
|
|
| contig05088 |
phosphatidylinositol n-acetylglucosaminyltransferase subunit p |
387 |
7 |
1.50E-10 |
84.43% |
0 |
|
|
|
| contig05089 |
histone mrna 3-exonuclease 1 |
392 |
2 |
6.08E-12 |
67.50% |
0 |
|
|
|
| contig05090 |
---NA--- |
216 |
0 |
|
|
0 |
|
|
|
| contig05091 |
---NA--- |
300 |
0 |
|
|
0 |
|
|
|
| contig05092 |
protein arginine methyltransferase 7 |
247 |
20 |
8.73E-35 |
72.95% |
10 |
P:regulation of protein binding; P:histone methylation; C:cytoplasm; F:[myelin basic protein]-arginine N-methyltransferase activity; P:peptidyl-arginine methylation; F:protein-arginine omega-N symmetric methyltransferase activity; F:histone-arginine N-methyltransferase activity; F:histone binding; F:protein-arginine omega-N monomethyltransferase activity; C:nucleus |
EC:2.1.1.126; EC:2.1.1.125 |
|
| contig05093 |
---NA--- |
324 |
0 |
|
|
0 |
|
|
|
| contig05094 |
---NA--- |
704 |
0 |
|
|
0 |
|
|
|
| contig05095 |
---NA--- |
285 |
0 |
|
|
0 |
|
|
|
| contig05096 |
novel protein human rearranged l-myc fusion sequence |
254 |
3 |
3.10E-27 |
71.33% |
0 |
|
|
|
| contig05097 |
peptidase d |
613 |
20 |
1.45E-98 |
92.00% |
7 |
F:manganese ion binding; F:X-Pro aminopeptidase activity; P:cellular amino acid metabolic process; F:metallocarboxypeptidase D activity; P:collagen catabolic process; P:proteolysis; F:X-Pro dipeptidase activity |
EC:3.4.11.9; EC:3.4.17.22; EC:3.4.13.9 |
|
| contig05098 |
---NA--- |
284 |
0 |
|
|
0 |
|
|
|
| contig05099 |
m-phase phosphoprotein 10 |
278 |
20 |
7.21E-13 |
57.70% |
7 |
P:rRNA processing; P:RNA splicing; ; C:small nucleolar ribonucleoprotein complex; F:protein binding; C:nucleus; C:nucleolus |
|
|
| contig05100 |
map3k12 binding inhibitory protein 1 |
412 |
20 |
2.71E-52 |
52.40% |
4 |
C:cytoplasm; F:protein kinase inhibitor activity; P:inactivation of MAPK activity involved in osmosensory signaling pathway; C:nucleus |
|
|
100 Rows returned.
Helpdesk 